CGON logo

CG Oncology, Inc. (CGON) EBIT

annual EBIT:

-$114.67M-$59.22M(-106.80%)
December 31, 2024

Summary

  • As of today (July 13, 2025), CGON annual earnings before interest & taxes is -$114.67 million, with the most recent change of -$59.22 million (-106.80%) on December 31, 2024.
  • During the last 3 years, CGON annual EBIT has fallen by -$102.28 million (-825.62%).
  • CGON annual EBIT is now -825.62% below its all-time high of -$12.39 million, reached on December 1, 2021.

Performance

CGON EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

quarterly EBIT:

-$42.20M-$4.16M(-10.92%)
March 31, 2025

Summary

  • As of today (July 13, 2025), CGON quarterly earnings before interest & taxes is -$42.20 million, with the most recent change of -$4.16 million (-10.92%) on March 31, 2025.
  • Over the past year, CGON quarterly EBIT has dropped by -$19.73 million (-87.83%).
  • CGON quarterly EBIT is now -353.08% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

TTM EBIT:

-$134.40M-$19.73M(-17.21%)
March 31, 2025

Summary

  • As of today (July 13, 2025), CGON TTM earnings before interest & taxes is -$134.40 million, with the most recent change of -$19.73 million (-17.21%) on March 31, 2025.
  • Over the past year, CGON TTM EBIT has dropped by -$66.21 million (-97.09%).
  • CGON TTM EBIT is now -1342.84% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CGON EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-106.8%-87.8%-97.1%
3 y3 years-825.6%-353.1%-1342.8%
5 y5 years-825.6%-353.1%-1342.8%

CGON EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-825.6%at low-353.1%at low-1342.8%at low
5 y5-year-825.6%at low-353.1%at low-1342.8%at low
alltimeall time-825.6%at low-353.1%at low-1342.8%at low

CGON EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$42.20M(+10.9%)
-$134.40M(+17.2%)
Dec 2024
-$114.67M(+106.8%)
-$38.05M(+34.5%)
-$114.67M(+19.5%)
Sep 2024
-
-$28.30M(+9.4%)
-$95.97M(+17.4%)
Jun 2024
-
-$25.85M(+15.1%)
-$81.72M(+19.8%)
Mar 2024
-
-$22.47M(+16.1%)
-$68.19M(+23.0%)
Dec 2023
-$55.45M
-$19.36M(+37.8%)
-$55.45M(+22.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$14.04M(+13.9%)
-$45.41M(+44.8%)
Jun 2023
-
-$12.33M(+26.8%)
-$31.36M(+64.8%)
Mar 2023
-
-$9.72M(+4.4%)
-$19.04M(+104.4%)
Dec 2022
-$35.25M(+184.5%)
-
-
Dec 2022
-
-$9.31M
-$9.31M
Dec 2021
-$12.39M
-
-

FAQ

  • What is CG Oncology, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual EBIT year-on-year change?
  • What is CG Oncology, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly EBIT year-on-year change?
  • What is CG Oncology, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM EBIT year-on-year change?

What is CG Oncology, Inc. annual earnings before interest & taxes?

The current annual EBIT of CGON is -$114.67M

What is the all time high annual EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual earnings before interest & taxes is -$12.39M

What is CG Oncology, Inc. annual EBIT year-on-year change?

Over the past year, CGON annual earnings before interest & taxes has changed by -$59.22M (-106.80%)

What is CG Oncology, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of CGON is -$42.20M

What is the all time high quarterly EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. quarterly EBIT year-on-year change?

Over the past year, CGON quarterly earnings before interest & taxes has changed by -$19.73M (-87.83%)

What is CG Oncology, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of CGON is -$134.40M

What is the all time high TTM EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. TTM EBIT year-on-year change?

Over the past year, CGON TTM earnings before interest & taxes has changed by -$66.21M (-97.09%)
On this page